The NHS in England will soon be able to offer blood group and HLA genotyping for the current cohort of people with sickle cell, thalassaemia and transfusion dependent rare anaemias, which will be funded by NHS England, free of charge to hospital trusts until March 2024.

Read the full document here

Comments are disabled.